|
1
|
Beck LH Jr and Salant DJ: Membranous
nephropathy: From models to man. J Clin Invest. 124:2307–2314.
2014.PubMed/NCBI View
Article : Google Scholar
|
|
2
|
Sekula P, Li Y, Stanescu HC, Wuttke M,
Ekici AB, Bockenhauer D, Walz G, Powis SH, Kielstein JT, Brenchley
P, et al: Genetic risk variants for membranous nephropathy:
Extension of and association with other chronic kidney disease
aetiologies. Nephrol Dial Transplant. 32:325–332. 2017.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Pozdzik A, Brochériou I, David C, Touzani
F, Goujon JM and Wissing KM: Membranous nephropathy and
anti-podocytes antibodies: Implications for the diagnostic workup
and disease management. Biomed Res Int.
2018(6281054)2018.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Ronco P and Debiec H: Pathogenesis of
membranous nephropathy: Recent advances and future challenges. Nat
Rev Nephrol. 8:203–213. 2012.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Sinico RA, Mezzina N, Trezzi B, Ghiggeri
GM and Radice A: Immunology of membranous nephropathy: From animal
models to humans. Clin Exp Immunol. 183:157–165. 2016.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Larsen CP, Messias NC, Silva FG, Messias E
and Walker PD: Determination of primary versus secondary membranous
glomerulopathy utilizing phospholipase A2 receptor staining in
renal biopsies. Mod Pathol. 26:709–715. 2013.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Zhang XD, Cui Z, Zhang MF, Wang J, Zhang
YM, Qu Z, Wang X, Huang J, Wang F, Meng LQ, et al: Clinical
implications of pathological features of primary membranous
nephropathy. BMC Nephrol. 19(215)2018.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Beck Lh Jr, Bonegio RG, Lambeau G, Beck
DM, Powell DW, Cummins TD, Klein JB and Salant DJ: M-type
phospholipase A2 receptor as target antigen in idiopathic
membranous nephropathy. N Engl J Med. 361:11–21. 2009.PubMed/NCBI View Article : Google Scholar
|
|
9
|
van den Brand JA, Hofstra JM and Wetzels
JF: Low-molecular-weight proteins as prognostic markers in
idiopathic membranous nephropathy. Clin J Am Soc Nephrol.
6:2846–2853. 2011.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Xu X, Wang G, Chen N, Lu T, Nie S, Xu G,
Zhang P, Luo Y, Wang Y, Wang X, et al: Long-term exposure to air
pollution and increased risk of membranous nephropathy in China. J
Am Soc Nephrol. 27:3739–3746. 2016.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Chiu HF, Chen H, Lu KC and Shu KH: Taiwan
Society of Nephrology: Distribution of glomerular diseases in
Taiwan: Preliminary report of national renal biopsy
registry-publication on behalf of Taiwan society of nephrology. BMC
Nephrol. 19(6)2018.PubMed/NCBI View Article : Google Scholar
|
|
12
|
da Silva AQB, de Sandes-Freitas TV, Mansur
JB, Medicina-Pestana JO and Mastroianni-Kirsztajn G: Clinical
presentation, outcomes, and treatment of membranous nephropathy
after transplantation. Int J Nephrol. 2018(3720591)2018.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Tu WH, Petitti DB, Biava CG, Tulunay O and
Hopper J Jr: Membranous nephropathy: Predictors of terminal renal
failure. Nephron. 36:118–124. 1984.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Saito T, Iwano M, Matsumoto K, Mitarai T,
Yokoyama H, Yorioka N, Nishi S, Yoshimura A, Sato H, Ogahara S, et
al: Mizoribine therapy combined with steroids and mizoribine blood
concentration monitoring for idiopathic membranous nephropathy with
steroid-resistant nephrotic syndrome. Clin Exp Nephrol. 21:961–970.
2017.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Kida H, Asamoto T, Yokoyama H, Tomosugi N
and Hattori N: Long-term prognosis of membranous nephropathy. Clin
Nephrol. 25:64–69. 1986.PubMed/NCBI
|
|
16
|
Tang Z, Wang Y, Tao L, Guo Y, Zheng Y and
Zheng D: The elevated levels of urinary angiotensinogen are
correlated with the severity of idiopathic membranous nephropathy.
BMC Nephrol. 19(357)2018.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Di J, Qian Q, Yang M, Jiang Y, Zhou H, Li
M and Zou Y: Efficacy and safety of long-course tacrolimus
treatment for idiopathic membranous nephropathy. Exp Ther Med.
16:979–984. 2018.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Huh H, Lee H, Lee JP, Kim DK, Oh S, Oh YK,
Kim YS and Lim CS: Factors affecting the long-term outcomes of
idiopathic membranous nephropathy. BMC Nephrol.
18(104)2017.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Liu YH, Chen CH, Chen SY, Lin YJ, Liao WL,
Tsai CH, Wan L and Tsai FJ: Association of phospholipase A2
receptor 1 polymorphisms with idiopathic membranous nephropathy in
Chinese patients in Taiwan. J Biomed Sci. 17(81)2010.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Xu NX, Xie QH, Sun ZX, Wang J, Li Y, Wang
L, Liu SJ, Xue J and Hao CM: Renal phospholipase A2 receptor and
the clinical features of idiopathic membranous nephropathy. Chin
Med J (Engl). 130:892–898. 2017.PubMed/NCBI View Article : Google Scholar
|
|
21
|
1999 World Health
Organization-International society of hypertension guidelines for
the management of hypertension. Guidelines subcommittee. J
Hypertens. 17:151–183. 1999.
|
|
22
|
Cattran DC, Feehally J and Terence Cook H:
Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group:
KDIGO2012 clinical practice guideline for the evaluation and
management of chronic kidney disease. Kidney Int (Suppl 3).
S1–S150. 2013. View Article : Google Scholar
|
|
23
|
Nair V, Robinson-Cohen C, Smith MR,
Bellovich KA, Bhat ZY, Bobadilla M, Brosius F, de Boer IH, Essioux
L, Formentini I, et al: Growth differentiation factor-15 and risk
of CKD progression. J Am Soc Nephrol. 28:2233–2240. 2017.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Cattran DC and Brenchley PE: Membranous
nephropathy: Integrating basic science into improved clinical
management. Kidney Int. 91:566–574. 2017.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Zhang Q, Huang B, Liu X, Liu B, Zhang Y,
Zhang Z, Hua J, Fan Y, Hu L, Meng M, et al: Ultrasensitive
quantitation of anti-phospholipase A2 receptor antibody as a
diagnostic and prognostic indicator of idiopathic membranous
nephropathy. Sci Rep. 7(12049)2017.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Roy S, Korula A, Basu G, Jacob S,
Varughese S and Tamilarasi V: Immunohistochemical glomerular
expression of phospholipase A2 receptor in primary and secondary
membranous nephropathy: A retrospective study in an Indian cohort
with clinicopathological correlations. Nephron Extra. 7:1–9.
2017.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Calvo-Río V, Loricera J, Mata C, Martín L,
Ortiz-Sanjuán F, Alvarez L, González-Vela MC, González-Lamuño D,
Rueda-Gotor J, Fernández-Llaca H, et al: Henoch-Schönlein purpura
in northern Spain: Clinical spectrum of the disease in 417 patients
from a single center. Medicine (Baltimore). 93:206–113.
2014.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Ayalon R and Beck LH Jr: Membranous
nephropathy: Not just a disease for adults. Pediatr Nephrol.
30:31–39. 2015.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Couser WG: Primary membranous nephropathy.
Clin J Am Soc Nephrol. 12:983–997. 2017.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Gupta S, Connolly J, Pepper RJ, Walsh SB,
Yaqoob MM, Kleta R and Ashman N: Membranous nephropathy: A
retrospective observational study of membranous nephropathy in
north east and central London. BMC Nephrol. 18(201)2017.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Yamaguchi M, Ando M, Katsuno T, Tsuboi N
and Maruyama S: Urinary protein and renal prognosis in idiopathic
membranous nephropathy: A multicenter retrospective cohort study in
Japan. Ren Fail. 40:435–441. 2018.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Heeringa SF, Branten AJ, Deegens JK,
Steenbergen E and Wetzels JF: Focal segmental glomerulosclerosis is
not a sufficient predictor of renal outcome in patients with
membranous nephropathy. Nephrol Dial Transplant. 22:2201–2207.
2007.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Ma YC, Zuo L, Chen JH, Luo Q, Yu XQ, Li Y,
Xu JS, Huang SM, Wang LN, Huang W, et al: Modified glomerular
filtration rate estimating equation for Chinese patients with
chronic kidney disease. J Am Soc Nephrol. 17:2937–2944.
2006.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Reidy K and Kaskel FJ: Pathophysiology of
focal segmental glomerulosclerosis. Pediatr Nephrol. 22:350–354.
2007.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Troyanov S, Roasio L, Pandes M, Herzenberg
AM and Cattran DC: Renal pathology in idiopathic membranous
nephropathy: A new perspective. Kidney Int. 69:1641–1648.
2006.PubMed/NCBI View Article : Google Scholar
|
|
36
|
Kuwabara M, Hisatome I, Niwa K, Hara S,
Roncal-Jimenez CA, Bjornstad P, Nakagawa T, Andres-Hernando A, Sato
Y, Jensen T, et al: Uric acid is a strong risk marker for
developing hypertension from prehypertension: A 5-year Japanese
cohort study. Hypertension. 71:78–86. 2018.PubMed/NCBI View Article : Google Scholar
|
|
37
|
Zhang BO, Cheng M, Yang M, Han S, Zhang
YH, Shi HG, Zhu L and Zhao XZ: Analysis of the prognostic risk
factors of idiopathic membranous nephropathy using a new surrogate
end-point. Biomed Rep. 4:147–152. 2016.PubMed/NCBI View Article : Google Scholar
|
|
38
|
Jolly SE, Mete M, Wang H, Zhu J, Ebbesson
SO, Voruganti VS, Comuzzie AG, Howard BV and Umans JG: Uric acid,
hypertension, and chronic kidney disease among Alaska Eskimos: The
genetics of coronary artery disease in alaska natives (GOCADAN)
study. J Clin Hypertens (Greenwich). 14:71–77. 2012.PubMed/NCBI View Article : Google Scholar
|
|
39
|
Ihm CG: Hypertension in chronic
glomerulonephritis. Electrolyte Blood Press. 13:41–45.
2015.PubMed/NCBI View Article : Google Scholar
|
|
40
|
Ponticelli C and Glassock RJ: Glomerular
diseases: Membranous nephropathy-a modern view. Clin J Am Soc
Nephrol. 9:609–616. 2014.PubMed/NCBI View Article : Google Scholar
|
|
41
|
Tomas NM, Beck LH Jr, Meyer-Schwesinger C,
Seitz-Polski B, Ma H, Zahner G, Dolla G, Hoxha E, Helmchen U,
Dabert-Gay AS, et al: Thrombospondin type-1 domain-containing 7A in
idiopathic membranous nephropathy. N Engl J Med. 371:2277–2287.
2014.PubMed/NCBI View Article : Google Scholar
|
|
42
|
Beck LH Jr, Fervenza FC, Beck DM, Bonegio
RG, Malik FA, Erickson SB, Cosio FG, Cattran DC and Salant DJ:
Rituximab-induced depletion of anti-PLA2R autoantibodies predicts
response in membranous nephropathy. J Am Soc Nephrol. 22:1543–1550.
2011.PubMed/NCBI View Article : Google Scholar
|
